CareDx, Inc. (NASDAQ:CDNA) has scheduled a conference call for 4th August 2020 at 4:30 PM Eastern Time to announce its 2Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.caredxinc.com
Earnings Expectation
CareDx, Inc. is set to announce second quarter earning results on Tuesday 4th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, CDNA to report 2Q20 loss of $ 0.04 per share from revenue of $ 35.61 million. For the full year, analysts anticipate top line of $ 155.11 million, while looking forward to loss of $ 0.02 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 165.00 million ~ $ 168.00 million
Click Here For More Historical Outlooks Of CareDx, Inc.
CareDx, Inc., a transplant diagnostics company, together with its subsidiaries, focuses on the discovery, development, and commercialization of diagnostic solutions for transplant patients worldwide. The company develops and provides a diagnostic surveillance testing solution for heart and kidney transplant recipients. It offers AlloMap, a heart transplant molecular test; and AlloSure, a donor-derived cell-free DNA test initially used for kidney transplant patients.
